Your browser doesn't support javascript.
loading
Pelvic metastatic squamous cell carcinoma of unknown primary site: A case report and brief literature review.
Zhu, Qi-Zhou; Li, Hui-Juan; Li, Yuan-Qiang; Yu, Xiao-Hong; Shu, Kuan-Yong.
Affiliation
  • Zhu QZ; Department of Gynecological Oncology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, People's Republic of China.
  • Li HJ; Medical Department, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, People's Republic of China.
  • Li YQ; Department of Gynecological Oncology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, People's Republic of China.
  • Yu XH; Department of Pathology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, People's Republic of China.
  • Shu KY; Department of Gynecological Oncology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, People's Republic of China.
Medicine (Baltimore) ; 102(52): e36796, 2023 Dec 29.
Article in En | MEDLINE | ID: mdl-38206704
ABSTRACT
RATIONALE Cancer with unknown primary site is a kind of disease that is difficult to deal with clinically, accounting for 2% to 9% of all newly diagnosed cancer cases. Here, we report such a case with pelvic metastatic squamous cell carcinoma of an unknown primary site and review the relevant literature. PATIENT CONCERNS DIAGNOSES A 43-year-old Chinese female patient was referred to our hospital and initially diagnosed as "malignant tumor of right adnexal area?, obstruction of right ureter, secondary hydronephrosis".

INTERVENTIONS:

Thereafter cytoreductive surgery was performed which included a total hysterectomy, left adnexectomy, partial omentum resection, pelvic lymph node dissection, and para-aortic lymph node dissection. The primary lesion could not be identified by supplementary examination and postoperative pathology. The patient was diagnosed as pelvic metastatic squamous cell carcinoma whose primary site was unknown. To prevent a recurrence, we administered adjuvant chemotherapy for the patient.

OUTCOMES:

The patient was followed up after treatment, complete remission has been maintained for 72 months, and no recurrence or metastasis has been found. LESSONS Our case demonstrates that surgery combined with chemotherapy could be helpful for pelvic metastatic squamous cell carcinoma of unknown primary site.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms, Unknown Primary / Carcinoma, Squamous Cell Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans Language: En Journal: Medicine (Baltimore) Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms, Unknown Primary / Carcinoma, Squamous Cell Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans Language: En Journal: Medicine (Baltimore) Year: 2023 Document type: Article Country of publication: